Description
Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion. Danish Kroner (approximately US$163 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor.
Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore.
Eivind Kolding succeeded Henrik Gürtler as CEO on 1 May 2014. Eivind Kolding left Novo Holdings A/S in March 2016 and Kasim Kutay took over as CEO for the organisation.